Three NKGen Biotech directors Klowden, Park, Scott resign; board shrinks to 2

NKGen Biotech, Inc.

Michael Klowden, Sangwoo Park, and Kathleen Scott resigned as directors effective Sept 29, 2024, one-year anniversary of service.
Resignations not due to any dispute with the company or board.
Board size temporarily reduced from 5 to 2 directors; committees each reduced to 1 member.
Board will seek new appointees within 180 days; discussions ongoing for Klowden and Scott reappointment.
CEO Paul Y. Song thanked the departing directors for their service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Klowden

director

NKGen Biotech, Inc.

Effective: 2024-09-29
Filed: October 3, 2024, 7:59 PM ET

On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company

Departed

Kathleen Scott

director

NKGen Biotech, Inc.

Effective: 2024-09-29
Filed: October 3, 2024, 7:59 PM ET

On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company

Departed

Sangwoo Park

director

NKGen Biotech, Inc.

Effective: 2024-09-29
Filed: October 3, 2024, 7:59 PM ET

On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Klowden resigned as director at NKGen Biotech, Inc..

Action: resigned
Role: director

Exact text from the filing

On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen Scott resigned as director at NKGen Biotech, Inc..

Action: resigned
Role: director

Exact text from the filing

On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sangwoo Park resigned as director at NKGen Biotech, Inc..

Action: resigned
Role: director

Exact text from the filing

On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company

View on SEC.gov

Source: SEC EDGAR

accession 0001213900-24-085116

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.